Comparison of lipid control therapy for hypercholesterolemic patients received aortic valve replacement
Not Applicable
- Conditions
- Hypercholestelomic patients with aortic valve replacement for aortic valve stemosis
- Registration Number
- JPRN-UMIN000006887
- Lead Sponsor
- Awaji Hospital, Hyogo, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient with a history of coronary artery disease 2. Patients with a history of sensitivity to statins 3. Patients with active hepatic disease(ALT or AST>100IU/L or total bilirubin>2.5mg/dL) 4. Patient on hemodialysis 5. Patients with fasting serum TG >= 1000 mg/dL. 6. Patients with CK > 500 IU/L. 7. Patients that are pregnant or potentially pregnant, patients breast-feeding, or patients aiming to become pregnant during the clinical trial. 8. Patients with drug abuse or alcoholic 9. Patients who are ineligible in the opinion of the investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method